Dr Martha Ann Hutson-fincher, MD | |
2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 | |
(479) 521-3363 | |
(479) 521-4167 |
Full Name | Dr Martha Ann Hutson-fincher |
---|---|
Gender | Female |
Speciality | Allergy & Immunology |
Location | 2100 N Green Acres Rd, Fayetteville, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417906371 | NPI | - | NPPES |
51679 | Other | AR | BCBS PROV # |
340675 | Other | AR | HEALTHLINK PROV# |
12197000000 | Other | AR | QUALCHOICE PROV# |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | C2705 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Martha Ann Hutson-fincher, MD 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 Ph: (479) 521-3363 | Dr Martha Ann Hutson-fincher, MD 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 Ph: (479) 521-3363 |
News Archive
When it comes to patient safety, all hospitals and U.S. states aren't created equal, according to the newly updated Hospital Safety Score. The Spring 2013 update to the Hospital Safety Score that assigns "A," "B," "C," "D" or "F" grades to more than 2,500 general hospitals in the United States showed hospitals have made only incremental progress in addressing errors, accidents, injuries and infections that kill or hurt their patients.
Pancreatic cancer is a particularly devastating disease. At least 94 percent of patients will die within five years, and in 2013 it was ranked as one of the top 10 deadliest cancers.
A high level of circulating tumor cells (CTCs) - cells that have detached from a tumor and are circulating in the body through the blood - are an independent prognostic marker in metastatic breast cancer as first-line therapy.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
› Verified 4 days ago
Dr. Laura Jane Koehn, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703 Phone: 479-521-3363 Fax: 479-521-4167 |